Liver cirrhosis trials in United Kingdom

In United Kingdom 18 Also abroad 360

18 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Where
Birmingham, London, Newcastle upon Tyne, Nottingham, Whitechapel
Age
18 years to 80 years
People
2,150 worldwide
Run by
Akero Therapeutics, Inc
See details and how to joinNCT06528314
Phase 3Taking people
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Where
Aberdeen, Bristol, Camberley, Derby, Edgbaston, Birmingham, Exeter, Glasgow, Hull, Liverpool, London, Newcastle upon Tyne, Northwood, Orpington, London, Preston, Rochdale, Sheffield, Southampton, Tooting, London, York
Age
18 years and over
People
1,590 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06632457 · EU 2024-513741-36-00
No phaseNot yet taking people in United Kingdom
Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
Where
Leeds, London
Age
18 years and over
People
10,000 worldwide
Run by
University Medical Center Groningen
See details and how to joinNCT07585890
Phase 2Taking people
Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Where
Newcastle upon Tyne
Age
18 years to 75 years
People
360 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT07631637 · EU 2026-525916-33-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Where
Aberdeen, Bristol, Leeds, London, Oxford, Plymouth, Portsmouth, Port Talbot, Southampton
Age
18 years to 75 years
People
1,800 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06419374 · EU 2023-510395-31-00
No phaseTaking people
A Novel Extracorporeal Liver Support Therapy In ALCF and to Evaluate the Efficacy of DIALIVE 2.0, a Liver Dialysis Device.
Where
London
Age
18 years to 70 years
People
72
Run by
Yaqrit Ltd
See details and how to joinNCT07347275
Phase 2Taking people
A-TANGO Phase 2 Study
Where
London
Age
18 years to 75 years
People
78
Run by
Yaqrit Ltd
See details and how to joinNCT06890039
Phase 2Withdrawn
A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).
Where
London
Age
18 years to 80 years
People
90 worldwide
Run by
European Foundation for Study of Chronic Liver Failure
See details and how to joinNCT05895136 · EU 2023-507073-18-00
No phaseTaking people
CirrhoCare- Using Smart-phone Technology to Enhance Care and Access to Treatment for Cirrhosis
Where
Birmingham, Brighton, Coventry, Liverpool, London, Nottingham, Oxford, Plymouth, Southampton, Torquay
Age
18 years and over
People
214
Run by
University College, London
See details and how to joinNCT06223893
Phase 3Taking people
A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis
Where
Basildon, Bournemouth, Bristol, Chelmsford, Derby, Dundee, Gateshead, Glasgow, Hull, Inverness, Leeds, London, Newcastle upon Tyne, Newport, Nottingham, Plymouth, Southampton, Torquay
Age
18 years and over
People
300
Run by
King's College London
See details and how to joinNCT06461208
Phase 3Taking people
Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites
Where
London
Age
18 years and over
People
240 worldwide
Run by
Aleksander Krag
See details and how to joinNCT05056220
No phaseTaking people
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
Where
Birmingham, Edinburgh, Leeds, London
Age
18 years to 80 years
People
3,000 worldwide
Run by
European Foundation for Study of Chronic Liver Failure
See details and how to joinNCT04613921
No phaseTaking people
Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer
Where
Bournemouth, Oxford
Age
18 years and over
People
300
Run by
University of Oxford
See details and how to joinNCT06658782
No phaseTaking people
A Simple Breath Test to Detect Liver Cancer and Monitor Liver Conditions
Where
London
Age
18 years and over
People
750
Run by
Imperial College London
See details and how to joinNCT06864195
No phaseTaking people
The European NAFLD Registry
Where
Birmingham, Cambridge, Gateshead, Hull, London, Newcastle upon Tyne, Nottingham, Oxford, Plymouth, Portsmouth
Age
18 years to 100 years
People
10,000 worldwide
Run by
Newcastle University
See details and how to joinNCT04442334
No phaseTaking people
Prospective Cohort for Early Detection of Liver Cancer
Where
Oxford
Age
18 years to 100 years
People
3,000
Run by
University of Oxford
See details and how to joinNCT05541601
No phaseTaking people
European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)
Where
Birmingham, Cambridge
Age
Up to 18 years
People
2,000 worldwide
Run by
Cambridge University Hospitals NHS Foundation Trust
See details and how to joinNCT04190849
No phaseTaking people
Nottingham Community Liver Biomarkers Cohort
Where
Nottingham
Age
18 years and over
People
2,000
Run by
University of Nottingham
See details and how to joinNCT02037867